PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product
Staci Gruber, Ph.D.
25 participants
Jun 27, 2024
INTERVENTIONAL
Conditions
Summary
This study is a clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions. The study will assess the impact of CBD on chronic pain symptoms, conventional medication use, clinical state, quality of life, cognition, and biomarkers.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
High-CBD, low-THC sublingual product formulated in palm oil
Placebo sublingual product formulated in palm oil with supplemental terpenes to match CBD product.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03984565